Literature DB >> 11230425

Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: a population-based prospective study of 301 pulmonary tuberculosis patients.

S Lockman1, J D Sheppard, C R Braden, M J Mwasekaga, C L Woodley, T A Kenyon, N J Binkin, M Steinman, F Montsho, M Kesupile-Reed, C Hirschfeldt, M Notha, T Moeti, J W Tappero.   

Abstract

Little is known about patterns of tuberculosis (TB) transmission among populations in developing countries with high rates of TB and human immunodeficiency virus (HIV) infection. To examine patterns of TB transmission in such a setting, we performed a population-based DNA fingerprinting study among TB patients in Botswana. Between January 1997 and July 1998, TB patients from four communities in Botswana were interviewed and offered HIV testing. Their Mycobacterium tuberculosis isolates underwent DNA fingerprinting using IS6110 restriction fragment length polymorphism, and those with matching fingerprints were reinterviewed. DNA fingerprints with >5 bands were considered clustered if they were either identical or differed by at most one band, while DNA fingerprints with < or =5 bands were considered clustered only if they were identical. TB isolates of 125 (42%) of the 301 patients with completed interviews and DNA fingerprints fell into 20 different clusters of 2 to 16 patients. HIV status was not associated with clustering. Prior imprisonment was the only statistically significant risk factor for clustering (risk ratio, 1.5; 95% confidence interval, 1.1 to 2.0). In three communities where the majority of eligible patients were enrolled, 26 (11%) of 243 patients overall and 26 (25%) of 104 clustered patients shared both a DNA fingerprint and strong antecedent epidemiologic link. Most of the increasing TB burden in Botswana may be attributable to reactivation of latent infection, but steps should be taken to control ongoing transmission in congregate settings. DNA fingerprinting helps determine loci of TB transmission in the community.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230425      PMCID: PMC87871          DOI: 10.1128/JCM.39.3.1042-1047.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

Authors:  A van Rie; R Warren; M Richardson; T C Victor; R P Gie; D A Enarson; N Beyers; P D van Helden
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

2.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

Authors:  J D van Embden; M D Cave; J T Crawford; J W Dale; K D Eisenach; B Gicquel; P Hermans; C Martin; R McAdam; T M Shinnick
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

3.  DNA fingerprinting of a national sample of Mycobacterium tuberculosis isolates, Botswana, 1995-1996.

Authors:  S Lockman; J D Sheppard; M Mwasekaga; T A Kenyon; N J Binkin; C R Braden; C L Woodley; D W Rumisha; J W Tappero
Journal:  Int J Tuberc Lung Dis       Date:  2000-06       Impact factor: 2.373

4.  Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures.

Authors:  P M Small; N B McClenny; S P Singh; G K Schoolnik; L S Tompkins; P A Mickelsen
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

5.  Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods.

Authors:  D Alland; G E Kalkut; A R Moss; R A McAdam; J A Hahn; W Bosworth; E Drucker; B R Bloom
Journal:  N Engl J Med       Date:  1994-06-16       Impact factor: 91.245

6.  Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and The Netherlands: usefulness of DNA typing for global tuberculosis epidemiology.

Authors:  P W Hermans; F Messadi; H Guebrexabher; D van Soolingen; P E de Haas; H Heersma; H de Neeling; A Ayoub; F Portaels; D Frommel
Journal:  J Infect Dis       Date:  1995-06       Impact factor: 5.226

7.  An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome.

Authors:  B R Edlin; J I Tokars; M H Grieco; J T Crawford; J Williams; E M Sordillo; K R Ong; J O Kilburn; S W Dooley; K G Castro
Journal:  N Engl J Med       Date:  1992-06-04       Impact factor: 91.245

8.  The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods.

Authors:  P M Small; P C Hopewell; S P Singh; A Paz; J Parsonnet; D C Ruston; G F Schecter; C L Daley; G K Schoolnik
Journal:  N Engl J Med       Date:  1994-06-16       Impact factor: 91.245

9.  Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients.

Authors:  C Beck-Sagué; S W Dooley; M D Hutton; J Otten; A Breeden; J T Crawford; A E Pitchenik; C Woodley; G Cauthen; W R Jarvis
Journal:  JAMA       Date:  1992-09-09       Impact factor: 56.272

10.  Restriction fragment length polymorphism analysis detecting a community-based tuberculosis outbreak among persons infected with human immunodeficiency virus.

Authors:  S R Tabet; G M Goldbaum; T M Hooton; K D Eisenach; M D Cave; C M Nolan
Journal:  J Infect Dis       Date:  1994-01       Impact factor: 5.226

View more
  26 in total

1.  Tuberculosis transmission in Botswana.

Authors:  S Bonora; M Boffito; S Audagnotto; G Di Perri
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis.

Authors:  Timothy Lahey; Siddharth Sheth; Mecky Matee; Robert Arbeit; C Robert Horsburgh; Lillian Mtei; Todd Mackenzie; Muhammad Bakari; Jenni M Vuola; Kisali Pallangyo; C Fordham von Reyn
Journal:  J Infect Dis       Date:  2010-10-15       Impact factor: 5.226

3.  First molecular epidemiology study of Mycobacterium tuberculosis in Burkina Faso.

Authors:  S Godreuil; G Torrea; D Terru; F Chevenet; S Diagbouga; P Supply; P Van de Perre; C Carriere; A L Bañuls
Journal:  J Clin Microbiol       Date:  2007-01-24       Impact factor: 5.948

4.  Molecular and conventional epidemiology of tuberculosis in Hong Kong: a population-based prospective study.

Authors:  Moira Chan-Yeung; Cheuk-Ming Tam; Harriet Wong; Chi-Chiu Leung; Julie Wang; Wing-Wai Yew; Chak-Wah Lam; Kai-Man Kam
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

Review 5.  Seventy Years of Tuberculosis Prevention: Efficacy, Effectiveness, Toxicity, Durability, and Duration.

Authors:  Nicole Salazar-Austin; David W Dowdy; Richard E Chaisson; Jonathan E Golub
Journal:  Am J Epidemiol       Date:  2019-12-31       Impact factor: 4.897

6.  What has Karonga taught us? Tuberculosis studied over three decades.

Authors:  A C Crampin; J R Glynn; P E M Fine
Journal:  Int J Tuberc Lung Dis       Date:  2009-02       Impact factor: 2.373

7.  Modeling the role of public transportation in sustaining tuberculosis transmission in South Africa.

Authors:  Jason R Andrews; Carl Morrow; Robin Wood
Journal:  Am J Epidemiol       Date:  2013-02-18       Impact factor: 4.897

8.  Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda.

Authors:  S Niemann; S Rüsch-Gerdes; M L Joloba; C C Whalen; D Guwatudde; J J Ellner; K Eisenach; N Fumokong; J L Johnson; T Aisu; R D Mugerwa; A Okwera; S K Schwander
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  Mycobacterium tuberculosis: an emerging disease of free-ranging wildlife.

Authors:  Kathleen A Alexander; Eve Pleydell; Mark C Williams; Emily P Lane; John F C Nyange; Anita L Michel
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

10.  Molecular epidemiology of tuberculosis in a sentinel surveillance population.

Authors:  Barbara A Ellis; Jack T Crawford; Christopher R Braden; Scott J N McNabb; Marisa Moore; Steve Kammerer
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.